Vital Signs

This week's collection of news and events from the School of Medicine

Anti-inflammatory Protein Promotes Healthy Gut Bacteria to Curb Obesity

Anti-inflammatory Protein Promotes Healthy Gut Bacteria to Curb Obesity

UNC School of Medicine researchers led by Jenny Ting, PhD, and colleagues, publish a new approach to weight loss and diabetes prevention.

Anti-inflammatory Protein Promotes Healthy Gut Bacteria to Curb Obesity - Read More…

UNC School of Medicine Hosts Annual White Coat Ceremony

UNC School of Medicine Hosts Annual White Coat Ceremony

The UNC School of Medicine’s Class of 2022 received their white coats at the annual event.

UNC School of Medicine Hosts Annual White Coat Ceremony - Read More…

Scientists Create Method to Map Vast Unknown Territory of Long Non-coding RNA

Scientists Create Method to Map Vast Unknown Territory of Long Non-coding RNA

UNC School of Medicine researchers led by Mauro Calabrese, PhD, have developed a way to categorize mysterious RNA molecules by their likely function, a big first step toward quickening the discovery of their roles in human health and diseases, such as cancers.

Scientists Create Method to Map Vast Unknown Territory of Long Non-coding RNA - Read More…

Findings could improve treatment for challenging acute leukemia in children

Findings could improve treatment for challenging acute leukemia in children

There is no consensus on the best way to treat mixed phenotype acute leukemia, a rare blood cancer with survival rates of between 47 and 75 percent for children. Researchers from St. Jude Children’s Research Hospital and the University of North Carolina Lineberger Comprehensive Cancer Center, led by Thomas Alexander, MD, MPH, have made important discoveries about the genetics of this disease that could lead to better treatments.

Findings could improve treatment for challenging acute leukemia in children - Read More…

Preliminary Data from Groundbreaking Genome Editing Clinical Trial Encouraging

Preliminary Data from Groundbreaking Genome Editing Clinical Trial Encouraging

As part of the phase 1 clinical trial for patients with Hunter syndrome, Joseph Muenzer, MD, PhD, performed the UNC Clinical Translational and Research Center's first-ever in vivo genome editing therapy, achieving a milestone in his own career.

Preliminary Data from Groundbreaking Genome Editing Clinical Trial Encouraging - Read More…

Smith awarded $8.5 million to compare treatments for recurrent bladder cancer

Smith awarded $8.5 million to compare treatments for recurrent bladder cancer

UNC Lineberger’s Angela B. Smith, MD, MS, an associate professor in the UNC School of Medicine Department of Urology and director of urologic oncology, and her collaborators were awarded a contract from the Patient-Centered Outcomes Research Institute to compare bladder removal with medical therapy in bladder cancer patients.

Smith awarded $8.5 million to compare treatments for recurrent bladder cancer - Read More…

Johnson Honored with Battle Distinguished Cancer Research Award

Johnson Honored with Battle Distinguished Cancer Research Award

Gary Johnson, PhD, the Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, and co-director of UNC Lineberger’s Molecular Therapeutics Program was awarded the 2017-2018 Hyman L. Battle Distinguished Cancer Research Award.

Johnson Honored with Battle Distinguished Cancer Research Award - Read More…

For her father, Morgan runs to support cancer research

For her father, Morgan runs to support cancer research

Katie Morgan, PharmD, a clinical pharmacist working with neuro-oncology and genitourinary-oncology patients at the N.C. Cancer Hospital, found her calling during her father's four-year battle with glioblastoma. To honor him and others fighting brain cancer, Morgan is running in the Head for the Cure 5K, which will be held Sept. 8 in Chapel Hill to raise money for brain cancer research.

For her father, Morgan runs to support cancer research - Read More…